Display Settings:

Format

Send to:

Choose Destination
See comment in PubMed Commons below
Fertil Steril. 2010 Aug;94(3):1138-40. doi: 10.1016/j.fertnstert.2009.11.030. Epub 2010 Jan 8.

The role of alendronate in mitigating perimenopausal bone loss: a double-blind randomized controlled pilot study.

Author information

  • 1Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California, San Francisco, California, USA. jmerse@med.unc.edu

Abstract

Compared with placebo, alendronate treatment resulted in a significant protection against bone loss in healthy perimenopausal women. This protection occurred at both the spine and the hip and was evident after 6 months of therapy.

Copyright (c) 2010 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.

PMID:
20056199
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Icon for Elsevier Science
    Loading ...
    Write to the Help Desk